Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00306774 · ClinicalTrials.gov registry record · Phase 2

Vitamin D to Slow Progression of Knee Osteoarthritis

A Phase 2 study of Osteoarthritis, Knee, sponsored by Tufts Medical Center.

Completed
Registry status
Phase 2
Development phase
146
Enrollment target
1
Study location

NCT00306774 is a Phase 2 study of Osteoarthritis, Knee that has completed, run by Tufts Medical Center. The registered enrollment target is 146 participants, below the 578-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00306774, a Phase 2 study of Osteoarthritis, Knee, has completed, sponsored by Tufts Medical Center.

COMPLETED
Registry status
Phase 2
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

Knee osteoarthritis (OA) is a common and disabling health problem in older adults and for which there is no cure. The purpose of this study is to determine the effects of vitamin D on knee OA symptoms and physical function in adults aged 45 years and older.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Vitamin D (cholecalciferol)

Study Locations (1)

Massachusetts

  • Tufts Medical Center, Division of Rheumatology - Boston

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2006-03
Est. Completion 2009-06
Phase Phase 2

Sponsor

Tufts Medical Center

169 total trials

What the Registry Record Tells You About NCT00306774

The ClinicalTrials.gov registry entry for NCT00306774 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 578-participant average among 91 other Osteoarthritis, Knee trials with a reported enrollment target (75% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00306774 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00306774 about?

NCT00306774 is a clinical study titled "Vitamin D to Slow Progression of Knee Osteoarthritis". Knee osteoarthritis (OA) is a common and disabling health problem in older adults and for which there is no cure. The purpose of this study is to determine the effects of vitamin D on knee OA symptoms and physical function in adults aged 45 years and older.

What is the current status of trial NCT00306774?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2006-03. Estimated completion is 2009-06.

What conditions does trial NCT00306774 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT00306774?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (cholecalciferol) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00306774?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00306774 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.